© American Consumer News, LLC dba MarketBeat® 2010-2021. Something went wrong while loading Watchlist. For the best MarketWatch.com experience, please update to a modern browser. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH)’s beta value is holding at 0, while the average true range (ATR) indicator is currently reading 0.86. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Start Your Risk-Free Trial Subscription Here, Russia to make Sputnik V vaccine in Italy; a 1st in EU, Anheuser-Busch Inbev Stock is a Must Own Re-Opening Play, GE, AerCap join air leasing businesses in $30 billion deal, Technology rebound leads stocks higher on Wall Street, ChargePoint Stock is a Speculative EV Play Only for the Nimble and Risk-Tolerant, US officials: report on oil and gas sale ban due by summer, FlexShopper Stock: Small Price, Big Upside, Casey's General Stores is Still a Good Buy, Why Visa (NYSE:V) Stock Deserves More Credit, Thor Industries (NYSE:THO) Deserves A Spot In Your Pantheon Of Stocks, Texas Roadhouse Looks Like a Post-Pandemic Winner, Purple Innovation Attempts Rebound After Earnings Dive, Great Time to Buy Goodyear Tires (NYSE: GT) Stock Here, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, Receive Analysts' Upgrades and Downgrades Daily. Their forecasts range from $20.00 to $35.00. The high price target for AUPH is $35.00 and the low price target for AUPH is $20.00. Here’s what the 2016 value rally says about how far the current advance can go, Campbell Soup Slips Because Life Will Change After Covid-19, Rideshare vehicle provider EVmo, formerly YayYo, takes part in fleet acquisition of Tesla EVs, Tesla stock’s rally adds $106 billion to EV maker’s market cap, Gold prices struggle for direction a day after sharpest daily rise in 2 months, AUPH will report 2021 earnings on 03/18/2022, AUPH will report Q1 2021 earnings on 05/19/2021, Americans debate which vaccine to ask for as Fauci advises taking what's offered. Aurinia Pharmaceuticals Inc Ordinary Shares (AUPH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The chart below shows how a company's share price and consensus price target have changed over time. With a 5-year investment, the revenue is expected to be around +205.36%. Want to see which stocks are moving? Average Target Price: 29.10: Number Of Ratings: 9: FY Report Date: 12/2021: Last Quarter's Earnings-0.05: Year Ago Earnings-0.99: Current Quarter's Estimate-0.36: Current Year's … By using this site you agree to the 4 Wall Street analysts that have issued a 1 year AUPH price target, the average AUPH price target is $32.00, with the highest AUPH stock price forecast at $35.00 and the lowest AUPH stock price … AUPH has a greater average analyst price target than 31.97% of stocks in the mid market cap category. View real-time stock prices and stock quotes for a full financial overview. Intraday Data provided by FACTSET and subject to terms of use. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Get short term trading ideas from the MarketBeat Idea Engine. Learn everything you need to know about successful options trading with this three-part video course. View detailed financial information, real-time news, videos, quotes and analysis on Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH). To see all exchange delays and terms of use please see disclaimer. Discover historical prices for AUPH stock on Yahoo Finance. 8 Wall Street analysts have issued ratings and price targets for Aurinia Pharmaceuticals in the last 12 months. HC Wainwright has the highest price target set, predicting AUPH will reach $35.00 … Learn about financial terms, types of investments, trading strategies and more. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. On average, they expect Aurinia … There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus rating of "Buy.". Learn more. MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Subscriber Agreement & Terms of Use, Identify stocks that meet your criteria using seven unique stock screeners. Based on our forecasts, a long-term increase is expected, the "AUPH" stock price prognosis for 2026-02-27 is 39.972 USD. Aurinia Pharm Target Price Projection Aurinia Pharm's current and average target prices are 15.65 and 29.75, respectively. 7 Wall Street analysts have set twelve-month price targets for Aurinia Pharmaceuticals in the last year. The high price target for AUPH is $35.00 and the low price target for AUPH is $20.00. Looking for new stock ideas? Privacy Notice, and Copyright © 2021 MarketWatch, Inc. All rights reserved. Aurinia Pharmaceuticals (NASDAQ: AUPH) was reported by SVB Leerink on 2021-01-27. This … Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Find real-time AUPH - Aurinia Pharmaceuticals Inc stock quotes, company profile, news and forecasts from CNN Business. Based on analysts offering 12 month price targets for AUPH in the last 3 months. The average price target is $29.00 with a high forecast of $35.00 and a low forecast of $23.00. Big movements in Aurinia Pharmaceuticals Inc stock price on Friday moving 11.99% between high and low (Updated on March 05, 2021) Sell candidate since 2021-03-04 Loss -2.39% PDF . There are currently 1 hold rating and 7 buy ratings for the stock, resulting in a consensus rating of … AUPH updated stock price target summary. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Get daily stock ideas top-performing Wall Street analysts. View daily, weekly or monthly format back to when Aurinia Pharmaceuticals Inc stock was issued. Get Aurinia Pharmaceuticals alerts: AUPH opened at $17.62 on Wednesday. This browser is no longer supported at MarketWatch. ... % rally in Aurinia's stock to $21.46. Their average twelve-month price target is $27.71, suggesting a possible upside of 98.0%. Fundamental company data provided by Zacks Investment Research. Explore commentary on Aurinia Pharmaceuticals Inc. and … View Price Target for AUPH Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. The latest price target for . Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. Aurinia Pharmaceuticals currently has a consensus rating of “Buy” and an average target price of $26.50. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). On the other hand, Aurinia Pharm's target price is what analysts think the stock … Their average twelve-month price target is $27.71, predicting that the stock has a possible upside of 111.24%. The dark blue line represents the company's actual price. Based on 6 analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. Create a list of the investments you want to track. Have Watchlists? All rights reserved. Do Not Sell My Information. and has now fallen 5 days in a row.During the day the stock … Historical and current end-of-day data provided by FACTSET. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. In that case, then, we find that the latest price level in today’s session is +111.23% off the targeted high while … AUPH: Get the latest Aurinia Pharmaceuticals stock price and detailed information including AUPH news, historical charts and realtime prices. View which stocks are hot on social media with MarketBeat's trending stocks report. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. The percent of analysts bearish on the stock of AUPH is less than nearly 100% of all US stocks. Stock analysis for Aurinia Pharmaceuticals Inc (AUPH:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. You can opt out at any time. Export data to Excel for your own analysis. Considering analysts have assigned the stock a price target range of $17.9-$30 as the low and high respectively, we find the trailing 12-month average consensus price target … The projected low price target is $17.9 while the price target rests at a high of $35. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. See what's happening in the market right now with MarketBeat's real-time news feed. The Aurinia Pharmaceuticals Inc stock price fell by -2.39% on the last day (Friday, 5th Mar 2021) from $13.41 to $13.09. Aurinia Pharmaceuticals Inc. NASDAQ Updated Mar 6, 2021 12:59 AM AUPH 13.09 0.32 (2.39%). Dow Jones, a News Corp company About WSJ. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AUPH stock is a recommendation set at 1.70. Royal Bank of Canada is very positive to AUPH and gave it a "Outperform" rating on … MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more. … According to . Cookie Notice (). Three of those contained upward price target revisions. Receive a free world-class investing education from MarketBeat. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. View our full suite of financial calendars and market data tables, all for free. Find the latest Aurinia Pharmaceuticals Inc (AUPH) stock quote, history, news and other vital information to help you with your stock trading and investing. AUPH | Complete Aurinia Pharmaceuticals Inc. stock news by MarketWatch. The analyst firm set a price target for 28.00 expecting AUPH to rise to … Visit a quote page and your recently viewed tickers will be displayed here. Please log in to your account or sign up in order to add this asset to your watchlist. The … The current price of Aurinia Pharm is the price at which Aurinia Pharm Ord is currently trading. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Post-Market 0.11 (0.84%) Log in to see them here or sign up to get started. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. There are currently no items in this Watchlist. … 8 Wall Street analysts have issued 1-year price targets for Aurinia Pharmaceuticals' shares. The lighter blue line represents the stock's consensus price target. All quotes are in local exchange time. Intraday data delayed at least 15 minutes or per exchange requirements. The firm …
Glastonbury Latest Rumours, Meghan Markle Interview Rekindles Princess, Toronto Fc Schedule 2021, Point Pleasant Beach Water Conditions, Lung Meridian Symptoms,